Cellectis Reports Financial Results for Third Quarter and First Nine Months 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Cellectis (CLLS) Tops Q3 EPS by 26c
November 6, 2019 5:23 PM ESTCellectis (NASDAQ: CLLS) reported Q3 EPS of ($0.54), $0.26 better than the analyst estimate of ($0.80). Revenue for the quarter came in at $2.19 million versus the consensus estimate of $3.28 million.
The third quarter of 2019 has been essential for our execution strategy, as we achieved a series of important key... More
